SYSTEMATIC REVIEW article
Front. Endocrinol.
Sec. Clinical Diabetes
Volume 16 - 2025 | doi: 10.3389/fendo.2025.1506652
This article is part of the Research TopicDisease-modifying approaches in type 1 diabetesView all 14 articles
Safety and efficacy of adjuvant Sotagliflozin therapy in patients with T1D -An Update and Systematic Review and Meta-Analysis
Provisionally accepted
- 1Zunyi Medical University, Zunyi, Guizhou Province, China
- 2First People’s Hospital of Zunyi, Zunyi, China
- 3cardiovascular medicine department, First People’s Hospital of Zunyi, Zunyi, China
- 4cardiovascular medicine department, Guizhou Aerospace Hospital, Zunyi, Guizhou Province, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
All experiments were conducted at the Scientific Research Center, the Space Hospital affiliated with Zunyi Medical University (Guizhou Aerospace Hospital). Y.L. and S.Y. conceived and designed the research. Y.Z. W.Z. and T.Q. examined the articles for logicality. All authors approved the final version of the manuscript and agreed to be accountable for all aspects of the work to ensure that questions associated with the accuracy or integrity of any part of the work are appropriately investigated and resolved. All persons designated as authors qualify for authorship, and all those who qualify are listed. FUNDING SUPPORT: Guizhou Provincial key discipline construction and development Fund. Mechanistic study of STRN-mediated microvessel thinning in myocardial fibrosis in SSH rats(Qiankehejichu -ZK[2022] General 583). Study the efficacy and mechanism of Shengmai Drink combined with ARNI in treating patients with CHF and hypotension (Zun Shi Ke He Zi (2021) 243).
Keywords: sotagliflozin, type 1 diabetes, SGLT1, SGLT2, Meta-analysis
Received: 05 Oct 2024; Accepted: 14 Mar 2025.
Copyright: © 2025 Lei, Yao, Wang, Tu, Jiang and Jiang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Qianfeng Jiang, cardiovascular medicine department, First People’s Hospital of Zunyi, Zunyi, China
Qianfeng Jiang, cardiovascular medicine department, Guizhou Aerospace Hospital, Zunyi, Guizhou Province, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.